Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions
“The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 4.1% while order intake rose by 4.4% organically.Business area Acute Care Therapies continues to be successful in handling the increased demand for ventilators, and the order intake in ECLS consumables remains high. The positive trend for Sterile Transfer in Life Science